Trial intelligence / Profile preview

CNS Prophylaxis With Liposome-Encapsulated Cytarabine in Adult ALL

NCT00795756Phase 3Completed

Sponsor
Northern Italy Leukemia Group
Start
Jan 2008
Primary completion
Oct 2013
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 3 trial of liposomal cytarabine in acute lymphoblastic leukemia (ALL), sponsored by Northern Italy Leukemia Group. Started Jan 2008; status: completed.

02

Drugs

liposomal cytarabine
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT00795756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00795756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call